share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  09/05 08:22
Moomoo AI 已提取核心信息
On August 30, 2024, Safety Shot, Inc., a Delaware-incorporated wellness and dietary supplement company, entered into a Securities Purchase Agreement with an accredited investor for the sale of 3,370,787 shares at $0.89 per share and an equal number of warrants at $0.125 each, with the warrants exercisable at $0.89 for five years from issuance. The investor is a family investment group, Core 4 Capital Corp., led by Safety Shot's President Jordan Schur, who owns 15% of the investor and whose immediate family members are also shareholders. The transaction, which did not involve any commissions, is expected to net the company approximately $3.421 million. The funds are intended for working capital, general corporate purposes, and the development and growth of the Safety Shot brand. This investment follows previous...Show More
On August 30, 2024, Safety Shot, Inc., a Delaware-incorporated wellness and dietary supplement company, entered into a Securities Purchase Agreement with an accredited investor for the sale of 3,370,787 shares at $0.89 per share and an equal number of warrants at $0.125 each, with the warrants exercisable at $0.89 for five years from issuance. The investor is a family investment group, Core 4 Capital Corp., led by Safety Shot's President Jordan Schur, who owns 15% of the investor and whose immediate family members are also shareholders. The transaction, which did not involve any commissions, is expected to net the company approximately $3.421 million. The funds are intended for working capital, general corporate purposes, and the development and growth of the Safety Shot brand. This investment follows previous investments by Core 4 totaling $6 million earlier in the year. The company has developed a patented product, Safety Shot, which is claimed to lower blood alcohol content and alleviate symptoms of excessive drinking. The product is available online and is being introduced to various business-to-business channels throughout 2024. The details of the investment are disclosed in the company's Current Report on Form 8-K filed on September 4, 2024.
2024年8月30日,总部位于特拉华州的保健和膳食补充品公司Safety Shot,Inc.与一家认可的投资者签订了证券购买协议,以每股0.89美元的价格出售了3,370,787股股票,以及相同数量的每张0.125美元的认股权证,认股权定价为0.89美元,有效期为从发行之日起的五年。投资者是Core 4 Capital Corp.家族投资集团,由Safety Shot的总裁Jordan Schur领导,他拥有该投资者15%的股份,其直系家庭成员也是股东。这笔交易没有涉及任何佣金,预计将为公司带来约342.1万美元的净额。这些资金用于营运资金、一般公司用途以及Safety Shot品牌的开发和增...展开全部
2024年8月30日,总部位于特拉华州的保健和膳食补充品公司Safety Shot,Inc.与一家认可的投资者签订了证券购买协议,以每股0.89美元的价格出售了3,370,787股股票,以及相同数量的每张0.125美元的认股权证,认股权定价为0.89美元,有效期为从发行之日起的五年。投资者是Core 4 Capital Corp.家族投资集团,由Safety Shot的总裁Jordan Schur领导,他拥有该投资者15%的股份,其直系家庭成员也是股东。这笔交易没有涉及任何佣金,预计将为公司带来约342.1万美元的净额。这些资金用于营运资金、一般公司用途以及Safety Shot品牌的开发和增长。这项投资是Core 4今年早些时候共计600万美元的先前投资的后续。公司研发了一款专利产品Safety Shot,据称可以降低血液酒精含量并缓解过量饮酒的症状。该产品可在线购买,并计划在2024年全年逐步引入各种商业渠道。投资细节已在公司于2024年9月4日提交的8-k表格的当前报告中披露。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息